SEATTLE--(BUSINESS WIRE)--Pacific Biometrics, Inc. (OTCBB:PBME)(“PBI”) has been awarded a contract worth an estimated $2.1 million with a top multinational pharmaceutical company (the “Sponsor”). This contract, related to a biological treatment for rheumatoid arthritis (RA), will provide essential laboratory data for a pivotal, global Phase III program.
